Sassi Aïcha, Maatouk Mouna, El Gueder Dorra, Bzéouich Imen Mokdad, Abdelkefi-Ben Hatira Saïda, Jemni-Yacoub Saloua, Ghedira Kamel, Chekir-Ghedira Leila
Laboratory of Cellular and Molecular Biology, Faculty of Dental Medicine, University of Monastir, Avicenne Street, Monastir, 5000, Tunisia; Unity of Bioactive Natural Substances and Biotechnology, Faculty of Pharmacy, University of Monastir, Avicenne Street, Monastir, 5000, Tunisia.
Laboratory of Cellular and Molecular Biology, Faculty of Dental Medicine, University of Monastir, Avicenne Street, Monastir, 5000, Tunisia; Unity of Bioactive Natural Substances and Biotechnology, Faculty of Pharmacy, University of Monastir, Avicenne Street, Monastir, 5000, Tunisia; University of Tunis-El Manar, Faculty of Sciences of Tunis, Tunisia.
Chem Biol Interact. 2018 Mar 1;283:10-19. doi: 10.1016/j.cbi.2017.11.022. Epub 2018 Jan 17.
Chrysin (5,7-dihydroxyflavone) is a natural and biologically active compound which has many biological activities as an anticancer agent. The current report is aimed at finding out whether the antitumor potential of chrysin, evidenced in vitro and in vivo, is linked or not to its effect on immunological mechanisms of melanoma-bearing mice. Chrysin-treated B16F10 cells were analyzed for their metabolic rate and apoptotic potentials. In vivo, BALB/c mice received a subcutaneous injection of B16F10 melanoma cells prior to antitumor treatments with chrysin (50 mg/kg b.w) for 14 days and 21 days. The results showed that chrysin inhibited cancer cell growth at a dose-dependent manner by inducing apoptosis and cell cycle arrest at G2/M phase. Moreover, chrysin suppressed melanoma tumor growth at an average of 60% (after 14 days of treatment) and 71% (after 21 days of treatment) compared to the tumor-bearing group. Furthermore, chrysin treatment increased the cytotoxic activity of NK, CTL and macrophages. The findings showed that chrysin antitumor action on the murine melanoma model was very promising, suggesting that chrysin could be a potentially good candidate for future use in alternative anti-melanoma treatments.
白杨素(5,7 - 二羟基黄酮)是一种天然的生物活性化合物,作为一种抗癌剂具有多种生物活性。本报告旨在探究白杨素在体外和体内所显示的抗肿瘤潜力是否与其对荷黑素瘤小鼠免疫机制的影响有关。分析了经白杨素处理的B16F10细胞的代谢率和凋亡潜力。在体内,BALB/c小鼠在接受白杨素(50 mg/kg体重)抗肿瘤治疗14天和21天之前,皮下注射B16F10黑素瘤细胞。结果表明,白杨素通过诱导细胞凋亡和使细胞周期停滞在G2/M期,以剂量依赖的方式抑制癌细胞生长。此外,与荷瘤组相比,白杨素治疗使黑素瘤肿瘤生长平均抑制了60%(治疗14天后)和71%(治疗21天后)。此外,白杨素治疗增强了自然杀伤细胞、细胞毒性T淋巴细胞和巨噬细胞的细胞毒活性。研究结果表明,白杨素对小鼠黑素瘤模型的抗肿瘤作用前景广阔,这表明白杨素可能是未来用于替代抗黑素瘤治疗的潜在优良候选药物。